Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Prior to acquisition by IFF in 2018 for $7.1 billion, Frutarom was one of the world’s largest suppliers of flavors, savory solutions, natural colors, antioxidants, enzymes and health ingredients for the food & beverage industry. Over 75% of its sales were from natural products. It had more than $1.6 billion in annual revenue at acquisition. No clinical results as it does not develop drugs.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Frutarom.